Alexion axes 20% of its global workforce
600 jobs lost amid restructure as firm moves to Boston life sciences hub
US pharmaceutical firm Alexion is to cut 20% of its global workforce and relocate its headquarters as part of an extensive restructuring programme. The company will close multiple sites, including its manufacturing facility in Rhode Island, US.